EUREKA TOKEN FROM EKA BLOCKCHAIN SOLUTIONS GMBH

EUREKA brings the Blockchain
EUREKA Blockchain Solutions GmbH (incorporation and registration in process), can become
a supplier of technology to publishers each indirectly and directly, and can develop all the
blockchain-based technology to alter a additional economical and trustworthy publication method
by introducing the EUREKA Platform for timestamping discoveries, gratifying reviewers and
decentralising publication.

Furthermore, the EUREKA token powers the REWARD system,
which supports to resolve basic problems inherent to the present research
systems. this enables publication homes, like ScienceMatters, to be one observation
publishing house whereas running their operations over the technology platform provided by EUREKA Blockchain Solutions GmbH. publication homes can paylicense fees to EUREKA
Blockchain Solutions GmbH for the utilization and integration of the EUREKA Platform.
ScienceMatters on blockchain - Introduction to the EUREKA Platform

The EUREKA Platform, operated by EUREKA Blockchain Solutions GmbH (incorporation
pending), may be a token-operated science publication scheme on a blockchain. mistreatment good
contracts on the EUREKA Platform, the full publication method – together with submission,
reviewing, rating, localised publication and funding selections are often created additional
efficient.

Problems and Solutions
Academia is facing well-documented serious challenges from current models for scholarly
publishing including:
a) Long delays in publication analysis
b) Overreliance of trust in researchers, peer reviewers and publishers that
creates unreliableness and unreliability in science
c) Absence of honest credit for contribution

The EUREKA Platform can alter establishments, universities, societies and funders to speedily deploy their own journals, with journal information and hashes recorded on Ethereum

The EUREKA peer-to-peer scientific knowledge publication platform are the primary to publish peer reviewed articles increased with a blockchain primarily based ratings and review system, referred to as ‘EUREKA’. ScienceMatters started publication articles in Feb 2016, and since then has conducted peer reviews and revealed analysis from university, the University of Oxford, the University of metropolis, furthermore as several alternative establishments.

The founding father of EUREKA and of ScienceMatters, Dr Lawrence Rajendran may be a faculty member of neurobiology at the University of metropolis and at the King’s school London and is thought in academic circles for his pioneering analysis into Alzheimer’s illness. His inspiration for EUREKA and ScienceMatters passed off due to his frustration with the constraints of the prevailing scientific business system. The Chair of the scientific planning board of ScienceMatters is Dr. Thomas Südhof, a faculty member at Stanford University UN agency was awarded the 2013 Nobel prize in Physiology or medication, and he options during a recent video clip supporting the project.

Currently, there's a winner-takes-all mentality wherever the primary research worker to publish a finding beats different researchers to the business line. the most scientific journals solely publish novel work, therefore the different researchers UN agency have conducted studies that make sure or solid doubt over results revealed elsewhere might ne'er themselves get published. This results in uncertainty on whether or not revealed analysis will be replicated.

The advantages of exploitation blockchain technology inside the research method are varied. First, information recorded on a blockchain is changeless and can't be tampered with. Secondly, it's redistributed and open, that means it will be verified by anyone. exploitation good contracts, we will automatize the transfer of ratings and rewards during a quick and truthful manner.

According to a survey of 1500 scientists conducted by the science journal Nature, quite seventieth are unable to breed another scientist’s experiments. Even a lot of worryingly, over fiftieth of these surveyed were unable to breed their own experiments.

As a result, abundant time and billions of greenbacks are wasted following drug candidates that have already been found in unpublished analysis to not be effective. this is often what's referred to as the ‘reproducibility’ crisis, and it's calculable that within the United States of America alone, $28 billion is wasted every year by pharmaceutical firms researching medication that are shown in trials to be ineffective or which have negative facet effects. EUREKA can modify firms to access replication studies, and wherever these are meagre or non-existent, corporations will incentivise and reward researchers on the EUREKA platform with EUREKA tokens for conducting replication studies round the world, so dashing up the method and saving analysis prices.

EUREKA tokens are going to be wont to reward reviewers to conduct peer reviews, to reward duplicability studies, reward studies that offer negative further as positive results and also modify funding of hypothesis and scientific proposals. The tokens also will grant choice rights to the holders, permitting them to influence selections place to a vote, and additionally to rate by upvoting and downvoting on scientific studies. Currently, most peer reviews are administrated free by lecturers UN agency have the posh of having the ability to gift their time to journals. This results in terribly long wait times, and it severely limits the quantity of articles that may be reviewed and revealed. By incentivising reviewers with EUREKA tokens which is able to vary mechanically betting on demand, this can accelerate the review method by creating peer reviewing accessible to a bigger pool of qualified lecturers. However, not solely reviewers will be incentivised, token payments also will move to documented authors.

REWARD System battery-powered by EUREKA

REWARD are going to be the system that underpins the platform at every stage of the analysis process: Revelation, Evaluation, value Assignment, Award, Replication, knowledge Analytics

Experienced team: The team behind EUREKA has expertise in science publication, computer code engineering and business development, and is from the established open access Swiss science publisher ScienceMatters World Wide Web.sciencematters.io

Prototype ready: A purposeful platform image and DAPP are developed in house, and a player are going to be completed by finish 2018

Software as a service: The EUREKA Platform can modify establishments, universities, societies and funders to apace deploy their own journals, with journal data and hashes recorded on Ethereum

First consumer in place: Sciencematters can integrate the EUREKA Platform in 2019

Established publication infrastructure: Editors, reviewers, and publication experience from ScienceMatters are going to be provided as a service to purchasers with journals running on the EUREKA Platform

Huge potential market: EUREKA can offer organisations with their own open access and 'Plan S' compatible journals. The eleven EU 'Plan S' countries have a complete analysis output of €10.81 billion each year

For additional data:

WEBSITE: https://eurekatoken.io
WHITEPAPER: https://eurekatoken.io/whitepaper_v3_1.pdf
FACEBOOK: https://www.facebook.com/TokenEureka/
TWITTER: https://twitter.com/TokenEureka/
TELEGRAM : https://t.me/EUREKAToken
LINKEDIN: https://www.linkedin.com/company/eurekatoken/
ANN THREAD: https://bitcointalk.org/index.php?topic=5043012

Author’s info:

BITCOINTALK USERNAME :cryptohot839373
BITCOINTALK : https://bitcointalk.org/index.php?action=profile;u=2404248